References
- S. De Rosa, M. Mitova, and G. Tommonaro, Biomol. Eng. 20, 311 (2003).
- V. Ivanova, H. Laatsch, M. Kolarova, and K. Aleksieva, Nat. Prod. Res. 27, 164 (2013).
- T.S. Bugni and C.M. Ireland, Nat. Prod. Rep. 21, 143 (2004).
- R. Huang, X. Zhou, T. Xu, X. Yang, and Y. Liu, Chem. Biodivers. 7, 2809 (2010).
- M.B. Martins and I. Carvalho, Tetrahedron 63, 9923 (2007).
- B. Nicholson, G.K. Lloyd, B.R. Miller, M.A. Palladino, Y. Kiso, Y. Hayashi, and S.T. Neuteboom, Anti-Cancer Drugs 17, 25 (2006).
- S. Sinha, R. Srivastava, E. DeClercq, and R.K. Singh, Nucleos. Nucleot. Nucl. 23, 815 (2004).
- D.R. Houston, B. Synstad, V.G.H. Eijsink, M.J.R. Stark, I.M. Eggleston, and D.M.F. van Aalten, J. Med. Chem. 47, 5713 (2004).
- S.N. Kumara, C. Mohandasa, and B. Nambisana, Peptides 53, 48 (2014).
- M.K. Song, I.K. Hwang, M.J. Rosenthal, D.M. Harris, D.T. Yamaguchi, I. Yip, and V. Go, Exp. Biol. Med. (Maywood) 228, 1338 (2003).
- T.D. Brooks, S. Wang, N. Brunner, and P.A. Charlton, Anti-Cancer Drugs 15, 37 (2004).
- J.R. Tonra, G.K. Lloyd, R. Mohanlal, and L. Huang, Cancer Chemother. Pharmacol. 85, 461 (2020).
- J. Davis, R. Benhaddou, R. Granet, P. Krausz, M. Demonte, and A.M. Aubertin, Nucleosides Nucleotides. 17, 875 (1998).
- L. Huck, J.F. González, E. Cuesta, J.C. Menéndez, and C. Avendaño, Org. Biomol. Chem. 9, 6271 (2011).
- J.F. González, E. Cuesta, and C. Avendaño, Bioorg. Med. Chem. 15, 112 (2007).
- G. Pescitelli, and T. Bruhn, Chirality 28, 466 (2016).
- S. Superchi, P. Scafato, M. Gorecki, and G. Pescitelli, Curr. Med. Chem. 25, 287 (2018).
- S.M. Zhang, L. Zhang, L.J. Kou, Q.L. Yang, B. Qu, G. Pescitelli, and Z.P. Xie, Chirality 32, 299 (2020).